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Abstract
Background:  Microarray analysis provides a powerful approach to identify gene expression
alterations following transplantation. In patients the heterogeneity of graft specimens, co-
morbidity, co-medications and the challenges in sample collection and preparation complicate
conclusions regarding the underlying mechanisms of graft injury, rejection and immune regulation.
Results: We used a rat kidney transplantation model with strict transplant and sample preparation
procedures to analyze genome wide changes in gene expression four days after syngeneic and
allogeneic transplantation. Both interventions were associated with substantial changes in gene
expression. After allogeneic transplantation, genes and pathways related to transport and
metabolism were predominantly down-regulated consistent with rejection-mediated graft injury
and dysfunction. Up-regulated genes were primarily related to the acute immune response
including antigen presentation, T-cell receptor signaling, apoptosis, interferon signaling and
complement cascades. We observed a cytokine and chemokine expression profile consistent with
activation of a Th1-cell response. A novel finding was up-regulation of several regulatory and
protective genes after allogeneic transplantation, specifically IL10, Bcl2a1, C4bpa, Ctla4, HO-1 and
the SOCS family.
Conclusion: Our data indicate that in parallel with the predicted activation of immune response
and tissue injury pathways, there is simultaneous activation of pathways for counter regulatory and
protective mechanisms that would balance and limit the ongoing inflammatory/immune responses.
The pathophysiological mechanisms behind and the clinical consequences of alterations in
expression of these gene classes in acute rejection, injury and dysfunction vs. protection and
immunoregulation, prompt further analyses and open new aspects for therapeutic approaches.
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Background
Microarray analyses have been used to link changes at the
level of gene expression to different kidney diseases to
obtain markers for diagnosis and prognosis. Microarray
analyses of human patients have been used to analyze
post-transplant events [1-6]. A recent review of microar-
ray-based studies and the search for biomarkers in organ
transplantation is given by Kurian et al. [7]. Microarray
analysis of kidney transplant biopsies with acute rejection
identified gene expression patterns that distinguish three
distinct subtypes of acute rejection that, although indis-
tinguishable by histology, were marked by differences in
mechanisms of immune activation and cell proliferation
[8]. Interestingly, another study of acute rejection biopsies
showed no evidence for up-regulation of cytotoxic T-cell
effector molecules despite the fact that these have been
considered markers for acute renal rejection [9]. In paral-
lel, gene expression signatures of peripheral blood lym-
phocytes (PBLs) from transplant patients have also been
shown to be capable of classifying patients with acute
rejection [6]. Surprisingly, there was essentially no overlap
in rejection-diagnostic genes up-regulated in PBL and
genes up-regulated in the biopsies from the same patients,
indicating that the blood must be considered a very differ-
ent immune compartment in this setting. As a conse-
quence of these initial studies, the hope of developing
validated diagnostic biomarkers for transplantation is
tempered by results that challenge an existing dogma on
immune response mechanisms and demand additional
studies to deconvolute.
There are a number of limitations inherent in clinical
studies of gene expression in transplantation. Patients typ-
ically represent major differences in gender, age, co-mor-
bidities, clinical histories, immunosuppressive regimes,
race/ethnicities, and genetics and it is always difficult to
collect samples at specific times relative to the procedures.
These differences significantly influence gene expression
and that operant variability compromises the results
obtained by microarray analysis as well as the confidence
to identify the principal underlying immune mechanisms.
The use of experimental transplantation models in rats or
mice is an opportunity to mitigate these variables and
work in a controlled system. Several studies have made
use of experimental transplantation to study changes in
gene expression related to acute rejection after murine
heart, kidney and lung transplantation [10-13]. While sev-
eral studies have been performed using heart transplanta-
tion in rats [14,15], to our knowledge, a study of acute
kidney transplant rejection in rats has not been reported.
In previous studies [16,17], we showed in well character-
ized rat renal transplantation models, no evidence of tis-
sue necrosis at day 4 while histological changes consistent
with acute rejection including activated lymphocyte infil-
tration were found consistently. In those studies we
showed differences in gene expression for selected sodium
and water transporters that were relevant to tissue injury
and renal compensation. In the present study, we made
use of these transplantation models and continued our
studies using day 4 as the measuring point to represent a
time at which there is full representation of acute rejection
mechanisms but before the widespread renal tissue injury
that can confuse the gene signatures. Thus, changes in
gene expression related solely to acute rejection in alloge-
neic transplantation or linked to the surgical procedure in
syngeneic transplantation can be evaluated. Native,
untreated kidneys were used as the control group. No
immunosuppression was used to specifically analyze the
influence of acute rejection on gene expression independ-
ent of the effects of immunosuppressive regimens.
Thereby, maximum homogeneity in procedures, sample
preparation, timing, and handling was achieved. In con-
trast to the design of renal transplantation studies per-
formed in mice [12,13], we used bilaterally
nephrectomized recipient rats, such that the animal's
transplant was required to maintain the full metabolic
and synthetic function of the organism as is the case in the
clinical transplant situation.
Results
Correlation and clustering of the samples
The global experiment structure was inspected utilizing
different methods intended to validate whether the
groups were homogeneous and whether the within-group
variance was smaller than the between-group variance.
Furthermore, group distances could be roughly estimated.
The correlations within the "acute group" (allogeneic kid-
ney transplant with acute rejection), "syngeneic group"
(syngeneic transplant as control for surgical changes) and
"control group" (untreated, native kidneys) showed a
homogenous correlation of 0.97–0.99 (Fig. 1A). The cor-
relation between the control group and the syngeneic
group was 0.95–0.97, between control and the acute
group was 0.84–0.87, and between the acute group and
the syngeneic group was 0.88–0.92. The representative
scatter plots of all genes between different samples
showed that the observed correlations are not dominated
by a small number of highly expressed genes (Fig. 1B).
The syngeneic group was more similar to the control
group than the acute group was to the control group.
Thus, the processes of acute rejection were the most rele-
vant factors in driving the observed changes in gene
expression.
Identification of differentially expressed genes
Significantly regulated and differentially expressed genes
were identified using class comparisons as implemented
in BRB ArrayTools for all the possible group comparisons
(acute to control, acute to syngeneic and syngeneic to con-BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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trol). Genes with a parametric p value < 0.001 were classi-
fied as significantly differentially expressed (Fig. 2A).
Thus, 3871 genes were up-regulated and 3483 were down-
regulated for the acute group compared to the control.
Comparison of the acute to the syngeneic group revealed
2668 genes were up- and 3236 genes were down-regu-
lated. In contrast, comparing the control to syngeneic
groups for the impact of the transplant surgery revealed
564 genes were down-regulated and 1291 were up-regu-
lated. The Venn diagram in Figure 2B shows the overlap
between the lists of significantly altered genes as a func-
tion of the three experimental groups. For further analysis
we used the gene lists from syngeneic transplants com-
pared to controls and from allogeneic transplants com-
pared to controls. Specifically, we decided not to report on
our comparison of the allogeneic transplants to the syn-
geneic transplants because the results of the functional
and pathway analysis were nearly identical with the
results obtained using the comparison of allogeneic trans-
plants with controls. There were marginal differences in
the number of genes related to a distinct function or path-
way. However, the complete output files with all regulated
genes are provided as additional file 1.
Genes with protective or regulatory properties up-regu-
lated after allogeneic transplantation like HO-1 (22 fold),
Bcl2a1 (59 fold), C4bpa (219 fold), IL10 (120 fold) or
members of a gene family that were highly induced like
TIMP1 (18 fold), MMP7 (15 fold), TAP1/2 (24/14 fold)
were analyzed by real time PCR (Fig. 2C and 2D). FoxP3
and CD25 are expressed by regulatory T-cells [18]. The
results for expression of genes that were not significantly
regulated after syngeneic transplantation according to the
array were set to 1. The PCR results confirmed the up-reg-
ulated genes after allogeneic transplantation identified by
the expression arrays. The changes in expression varied
between 10-fold for Tap2 up to ~500-fold for C4bp. It is
important to note that there is no corresponding probe set
on the Rat 230 2.0 microarray for FoxP3. Therefore the
FoxP3 was also chosen for Real-Time PCR analysis. Inter-
estingly the expression of FoxP3 was highly induced after
allogeneic transplantation (~14 fold).
The genes analyzed by real time PCR were not identified
to be differently expressed after syngeneic transplantation
compared to control. However, the real time PCR results
showed up-regulated expression of MMP7 (~21-fold) and
C4bp (~13-fold) after syngeneic transplantation.
Genes involved in immune response
A selection of transcripts determined to be up-regulated as
a function of acute rejection is shown in Table 1. The
recruitment of cells related to the immune response is
indicated by up-regulation of CD8 (229-fold), the marker
for cytotoxic T-cells and by the up-regulation of
granzyme-A (67-fold), granzyme-B (103-fold) and per-
forin (25-fold), cytotoxic effector molecules released by
CD8+ T-cells. Evidence for the involvement and activation
of macrophages is the elevated expression of CD163, the
marker for macrophages [19] and ficolin B, which is
expressed by activated macrophages [20].
T-cells and macrophages release factors like cytokines for
differentiation and proliferation and chemokines for
recruitment of other immunologically active cells. Thus, 
Correlation and clustering of the samples Figure 1
Correlation and clustering of the samples. A) Correla-
tion analyses of the samples showed the expected results 
with higher correlation between control group (ctr) and syn-
geneic group (sTX) samples compared to acute rejection 
group (aTX). B) The representative scatter plots of all genes 
between different samples shows, that the observed correla-
tion is not dominated by a small number of high-expressing 
genes.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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Differently expressed genes between the control, syngeneic and allogeneic group Figure 2
Differently expressed genes between the control, syngeneic and allogeneic group. Class comparisons were performed using BRB array tools to 
identify genes with significant changes in expression levels between the syngeneic group (sTX_con) or the allogeneic group (aTX_con) compared to the 
control group and between allogeneic and syngeneic group (aTX_sTX; Fig. 2A). Genes with a p-value < 0.001 were classified as significant regulated. The 
complete lists with the significant regulated genes are provided with this manuscript (see additional file 1). The Venn diagram in Fig. 2B shows the number 
of overlapping genes. The changes in expression compared to control for selected genes were analyzed by real time PCR using specific primer pairs or Taq-
Man gene expression assays. Relative changes were evaluated using the 2-ΔΔCt method. The changes in gene expression after allogeneic transplantation are 
shown in Fig. 2C and the results for the syngeneic transplantation group in Fig. 2D. The black columns show the corresponding expression levels on the 
arrays (ratio of mean signal intensities). MMP7. IL10, C4bpa, Tap1 and Tap2 were not differently expressed after syngeneic transplantation on the array. 
There was no corresponding probe set for FoxP3 on the array.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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Table 1: Selection of significant up-regulated expression of cytokines, cytokine receptors, chemokines, chemokine receptors, 
regulatory or protective genes after allogeneic transplantation compared to control group.
Fold change Probe set Description Gene symbol
Cytokines
121.2 1387711_at interleukin 10 Il10
84.1 1370790_at interferon gamma Ifng
41.6 1391384_at tumor necrosis factor (TNF superfamily, member 2) Tnf
15.4 1398256_at interleukin 1 beta Il1b
13.1 1368592_at interleukin 1 alpha Il1a
8.6 1369665_a_at interleukin 18 Il18
8.4 1368763_at interleukin 3 Il3
7.4 1369191_at interleukin 6 Il6
6.1 1369208_at interleukin 7 Il7
Cytokine receptors
17 1389092_at interleukin 2 receptor, gamma Il2rg
13.6 1387591_at interleukin 2 receptor, alpha chain Il2ra
11.8 1369697_at interleukin 8 receptor, beta Il8rb
10.1 1387394_at interleukin 2 receptor, beta chain Il2rb
3.5 1370728_at interleukin 13 receptor, alpha 1 Il13ra1
3 1386987_at interleukin 6 receptor Il6r
Chemokines
139.7 1382454_at chemokine (C-X-C motif) ligand 9 Cxcl9
122.8 1387831_at small inducible cytokine subfamily C, member 1 (lymphotactin) Xcl1
39.3 1387969_at chemokine (C-X-C motif) ligand 10 Cxcl10
25.7 1391925_at chemokine (C-C motif) ligand 19 (predicted) Ccl19_predicted
21.5 1369815_at chemokine (C-C motif) ligand 3 Ccl3
17.5 1367973_at chemokine (C-C motif) ligand 2 Ccl2
16.5 1379365_at chemokine (C-X-C motif) ligand 11 Cxcl11
15.2 1370832_at small inducible cytokine A4 Ccl4
6.7 1387316_at chemokine (C-X-C motif) ligand 1 Cxcl1
5.8 1369983_at chemokine (C-C motif) ligand 5 Ccl5
Chemokine receptors
55.9 1369290_at chemokine (C-C) receptor 5 Ccr5
53.5 1370083_at macrophage inflammatory protein-1 alpha receptor gene Ccr1
45.9 1393929_at chemokine (C-C motif) receptor 6 (predicted) Ccr6_predicted
41.1 1387742_at chemokine (C-C motif) receptor 2 Ccr2
11.2 1368192_at chemokine (C-X-C motif) receptor 3 Cxcr3
Regulatory or protective genes
219.364 1369764_at complement component 4 binding protein, alpha C4bpa
121.25 1387711_at interleukin 10 Il10
55.975 1368482_at B-cell leukemia/lymphoma 2 related protein A1 Bcl2a1
39.519 1371252_at suppressor of cytokine signaling 1 Socs1
39 1387835_at interleukin 1 receptor antagonist Il1rn
36.72 1387608_at indoleamine 2,3-dioxygenase Indo
28.885 1382622_at cystatin F (leukocystatin) (predicted) Cst7_predicted
23.06 1370080_at heme oxygenase (decycling) 1 Hmox1
17.922 1370113_at inhibitor of apoptosis protein 1 Birc3
16.732 1368695_at complement component 4 binding protein, beta C4bpb
8.305 1387638_a_at cytotoxic T-lymphocyte-associated protein 4 Ctla4
Immune cells related genesBMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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the expression pattern of cytokines and chemokines like
Cxcl9, Xcl1, Cxcl10 or Ccl3 shown in Table 1 is consistent
with their well established importance in the signaling
mechanisms activated after allogeneic transplantation
(for review see [21]).
Functional annotation using gene ontology terms
To identify activated or suppressed functions, the lists of
significantly up- or down-regulated genes after syngeneic
transplantation and allogeneic transplantation were ana-
lyzed to identify over-represented GO-terms. The third
GO-level gives the best compromise between specificity
and list coverage [22]. After syngeneic transplantation, 18
GO-terms were enriched in the up-regulated and 1 in the
down-regulated group of genes on GO-level 3. We also
analyzed over-represented GO-terms without filtering on
the third level. Table 2 shows the ten most significant
over-represented genes related to biological process (BP),
cellular component (CC) and molecular function (MF).
Due to the limitation of space the complete lists are also
provided with this manuscript (see additional file 2).
Decreased expression of metabolism-related genes after
syngeneic transplantation suggests the suppression of BP-
related genes. Increased expression of genes related to
"cell proliferation" and "cell cycle" within the BP category,
"extra cellular matrix" and "collagen" within the CC cate-
gory and "collagen binding" within the MF category reveal
the activation of tissue injury recovery mechanisms
related to the transplant surgery itself.
After allogeneic transplantation, 58 GO-terms were signif-
icantly enriched in the up-regulated and 29 in the down-
regulated genes on GO-level 3. Without the application of
any filter, 250 GO-terms were enriched in the up- and 119
in the down-regulated set of genes. Table 3 shows the ten
most significant over-represented genes related to BP, CC
and MF. As expected, the increased expression of genes
related to the BP categories "immune response", "defense
response" and the CC category "T-cell receptor complex"
and the MF category called "cytokine binding" indicates
the activation of the immune response. These GO-terms
are consistent with infiltration of the graft by T-cells and
describe signaling mechanisms involved in activation, dif-
ferentiation and recruitment of immune cells. The BP 'cell
death' group describes the downstream processes follow-
ing T-cell activation. The decreased expression of genes
related to the BP categories "metabolism", "transport",
"excretion" and the MF category "primary active trans-
porter activity" indicates the challenges posed to the graft
to maintain renal function. A major part of renal function
is mediated by several transporters and transport systems
all primarily or secondarily coupled to energy consump-
tion. The down-regulation of genes that are involved in
metabolism or transport leads to a decreased tubular func-
tion of the kidney.
Pathways affected after syngeneic and allogeneic 
transplantation
The functional annotation with DAVID identified path-
ways related to the Kyoto Encyclopedia of Genes and
Genomes (KEGG) [23] that were affected after syngeneic
or allogeneic transplantation. The pathways affected after
syngeneic transplantation are listed in Table 4. The major-
ity of down-regulated genes are related to metabolism
pathways. Increased expression of genes involved in "cell
cycle" and "extra cellular matrix (ECM)-receptor interac-
tion" are suggestive of active recovery processes following
the surgery.
Pathways with enrichment of down- or up-regulated
genes after allogeneic transplantation are listed in Table 4.
The majority of the pathways with down-regulated genes
are also related to metabolism. In all cases the numbers of
genes related to metabolism pathways were higher after
allogeneic than syngeneic transplantation indicating a
stronger suppression of these pathways in the context of
acute rejection. But some pathways, however, were
affected only after allogeneic transplantation, like 'oxida-
tive phosphorylation', 'citrate cycle' or 'metabolism of
xenobiotics by cytochrome p450' indicating an acute
rejection mediated down-regulation of genes related to
these pathways. The majority of pathways with enrich-
229.344 1385414_at CD8 antigen, alpha chain Cd8a
144.253 1387378_at ficolin B Fcnb
103.106 1370628_at granzyme B Gzmb
67.326 1379293_at granzyme A Gzma
35.114 1393917_at CD163 antigen (predicted) Cd163_predicted
30.581 1387472_at CD3 antigen delta polypeptide Cd3d
28.319 1387739_at CD8 antigen, beta chain Cd8b
25 1370096_at perforin 1 (pore forming protein) Prf1
18.368 1370483_at CD244 natural killer cell receptor 2B4 Cd244
Table 1: Selection of significant up-regulated expression of cytokines, cytokine receptors, chemokines, chemokine receptors, 
regulatory or protective genes after allogeneic transplantation compared to control group. (Continued)BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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ment in up-regulated genes can be directly or indirectly
linked to the immune response.
To illustrate the pathways activated by acute rejection
related to the immune response, we used IPA to map net-
works of up- and down-regulated genes after allogeneic
transplantation to functional pathways for antigen-pres-
entation (Fig. 3), TCR-signaling (Fig. 4), apoptosis (Fig.
5), IFNγ (Fig. 6) and complement cascades (Fig. 7).
Within the antigen processing and presentation pathway
Table 2: Overrepresented GO categories compared to control within the syngeneic transplantation group. The top 10 significantly 
overrepresented GO categories on the third level (p < 0.05, Fisher's exact test, with Benjamini and Hochberg correction) related to 
biological process (BP), cellular component (CC) and molecular function (MF) in the set of genes down- or up-regulated after 
syngeneic transplantation (sTX) compared to control are shown in Table 2 The numbers indicate the quantity of genes corresponding 
with the GO-terms.
sTX_down
Category Term Count p-value
BP organic acid metabolism 57 1,1E-10
BP carboxylic acid metabolism 56 1,5E-10
BP amino acid and derivative metabolism 41 7,1E-9
BP amino acid metabolism 31 2,2E-6
BP nitrogen compound metabolism 40 8,3E-6
BP amine metabolism 38 9,7E-6
BP sulfur amino acid metabolism 10 1,8E-5
BP amino acid derivative metabolism 18 6,0E-5
BP amino acid catabolism 13 1,1E-4
BP nitrogen compound catabolism 15 1,2E-4
CC mitochondrion 59 1,9E-7
CC microbody 14 4,0E-4
CC peroxisome 14 4,0E-4
MF oxidoreductase activity 59 3,2E-9
MF catalytic activity 195 1,5E-6
MF lyase activity 20 1,7E-3
sTX_up
BP mitotic cell cycle 44 5,3E-7
BP cell division 30 6,1E-7
BP cell cycle 81 6,8E-7
BP cell adhesion 70 2,5E-6
BP mitosis 29 2,6E-6
BP M phase of mitotic cell cycle 29 2,7E-6
BP cell proliferation 83 1,1E-5
BP M phase 33 3,9E-5
BP regulation of cell cycle 54 7,9E-5
BP regulation of progression through cell cycle 54 7,9E-5
CC extracellular matrix 56 3,5E-16
CC extracellular matrix (sensu Metazoa) 54 2,7E-15
CC intracellular non-membrane-bound organelle 144 6,0E-13
CC non-membrane-bound organelle 144 6,0E-13
CC collagen 16 2,0E-7
CC ribosome 36 2,4E-5
CC cytoskeleton 76 4,1E-5
CC spindle 17 4,1E-5
CC microtubule cytoskeleton 40 4,2E-5
CC chromosome 36 4,4E-5
MF structural molecule activity 75 3,7E-8
MF extracellular matrix structural constituent 23 9,6E-8
MF structural constituent of ribosome 32 9,3E-5
MF collagen binding 8 1,7E-2
MF pattern binding 17 4,3E-2
MF enzyme inhibitor activity 29 4,7E-2BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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Table 3: Overrepresented GO categories compared to control within the allogeneic transplantation group. The top 10 significantly 
overrepresented GO categories on the third level (p < 0.05, Fisher's exact test, with Benjamini and Hochberg correction) related to 
biological process (BP), cellular component (CC) and molecular function (MF) in the set of genes down- or up-regulated after 
allogeneic transplantation (aTX) compared to control are shown in Table 3. The numbers indicate the quantity of genes 
corresponding with the GO-terms.
aTX_down
Category Term Count p-value
BP nitrogen compound metabolism 119 8,1E-11
BP catabolism 130 3,7E-6
BP cellular metabolism 864 3,9E-4
BP transport 408 5,1E-4
BP establishment of localization 459 1,4E-3
BP excretion 18 5,1E-3
CC organelle inner membrane 110 1,7E-25
CC mitochondrial envelope 116 1,1E-23
CC organelle envelope 128 1,9E-15
CC cytoplasm 695 5,8E-15
CC organelle membrane 165 9,3E-15
CC mitochondrial lumen 41 4,6E-7
CC membrane fraction 171 8,8E-7
MF electron carrier activity 45 7,6E-17
MF oxidoreductase activity, acting on NADH or NADPH 37 1,8E-12
MF primary active transporter activity 55 2,5E-8
MF metal ion transporter activity 39 4,3E-7
MF oxidoreductase activity, acting on the CH-CH group of donors 22 8,8E-6
MF oxidoreductase activity, acting on CH-OH group of donors 38 1,1E-4
MF coenzyme binding 21 2,0E-4
aTX_up
BP immune response 283 1,7E-44
BP defense response 292 8,1E-43
BP response to pest, pathogen or parasite 180 6,4E-26
BP response to other organism 180 2,3E-24
BP macromolecule metabolism 797 1,4E-23
BP cell activation 78 2,7E-14
BP cell death 198 1,9E-13
BP response to wounding 141 1,8E-11
BP primary metabolism 1079 8,0E-9
BP cell cycle 171 2,2E-8
CC ribonucleoprotein complex 138 1,7E-22
CC intracellular non-membrane-bound organelle 318 3,9E-18
CC nucleus 581 3,0E-12
CC ribosome 81 1,2E-11
CC cytosolic small ribosomal subunit (sensu Eukaryota) 23 2,2E-8
CC T cell receptor complex 14 1,5E-6
CC nuclear envelope 44 2,0E-5
CC intracellular organelle 1000 2,3E-5
CC spliceosome complex 25 9,6E-5
CC proteasome complex (sensu Eukaryota) 25 1,5E-4
MF RNA binding 178 3,5E-31
MF cytokine binding 30 8,5E-4
MF sugar binding 36 6,8E-3
MF translation factor activity, nucleic acid binding 33 8,6E-3
MF translation initiation factor activity 22 1,3E-2
MF protease activator activity 10 4,3E-2BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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nearly all genes were affected (Fig. 3). The immunoprotea-
some alters the activity of the proteasome by replacement
of the β1, β2 and β5 subunits of the 20S core proteasome
by LMP2, LMP7 and Psmb10 [24]. The expression of these
subunits was strongly induced by acute rejection. The
antigens processed by the proteasome are transported by
molecules associated with the antigen processing (TAP)
complex [25]. Thus, we saw strong induction of TAP1 (24-
fold) and TAP2 (15-fold; Fig. 2C).
The recognition of allogeneic MHC by the T-cell's cognate
antigen receptor (TCR) will induce activation signals and
transcriptional activity (Fig. 4). The gene expression
changes indicate an induction of NFATc1 and NF-κB
related pathways. Within these pathways, genes with
counter regulatory properties like CTLA-4 or cbl were also
up-regulated.
Fig. 6 illustrates the signaling pathway for IFNγ. IFNγ acts
as a pro-inflammatory cytokine with altered expression
after allogeneic transplantation (Table 1). Nearly all the
genes within this pathway showed altered expression in
the setting of acute rejection. The expression of signal
transducer and activator of transcription (STAT) 1 and
STAT 2, the downstream effectors of IFNγ signaling, was
highly induced. But the increased expression of the sup-
pressor of cytokine signaling (SOCS) 1 and of the protein
tyrosine phosphatase non-receptor type 2 (TC-PtP), both
negative regulators of IFNγ signaling, indicate the simulta-
neous activation of regulatory mechanisms to limit the
IFNγ signaling.
Potential novel markers for acute rejection
Several genes in the list of up-regulated genes after alloge-
neic transplantation might serve as novel markers for
Table 4: Pathways with up- or down-regulated genes after syngeneic transplantation or allogeneic transplantation. Pathway charts 
were obtained using DAVID functional annotation tools (p < 0.05, Fisher's exact test, p-value with Benjamini correction). Pathways 
with a significantly elevated number of genes down- or up-regulated after syngeneic transplantation (sTX) or allogeneic 
transplantation (aTX) compared to control are shown Table 4. The numbers indicate the genes affected within the pathways.
sTX-down sTX-up
Pathway Count Pathway Count
tryptophan metabolism 13 ribosome 22
methionine metabolism 7 cell cycle 28
valine, leucine and isoleucine degradation 11 ribosome 13
lysine degradation 9 focal adhesion 31
fatty acid metabolism 11 ecm-receptor interaction 16




selenoamino acid metabolism 6
caprolactam degradation 5
alkaloid biosynthesis II 5
limonene and pinene degradation 5
glycine, serine and threonine metabolism 7
aTX-down aTX-up
Pathway Count Pathway Count
oxidative phosphorylation 48 antigen processing and presentation 46
fatty acid metabolism 29 ribosome 43
valine, leucine and isoleucine degradation 25 cell cycle 50
glutathione metabolism 21 proteasome 22
citrate cycle (tca cycle) 13 t cell receptor signaling pathway 45
pyruvate metabolism 17 type I diabetes mellitus 28
butanoate metabolism 20 hematopoietic cell lineage 33
glycine, serine and threonine metabolism 17 cell adhesion molecules (cams) 50
metabolism of xenobiotics by cytochrome p450 23 cytokine-cytokine receptor interaction 48
tryptophan metabolism 21 toll-like receptor signaling pathway 26
propanoate metabolism 14
reductive carboxylate cycle (CO2 fixation) 6BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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acute rejection (Table 5). One candidate is the ETS tran-
scription factor, Spic (SPI-C; 113-fold). SPI-C is expressed
during B-lymphocyte development and in activated mac-
rophages [26]. SPI-C also interacts with STAT6 promoting
IL4 dependent IgE expression [27]. No elevated expres-
sion level of IL4 and only a marginal up-regulation of
STAT6 after allogeneic transplantation were found so that
the function of SPI-C remains unclear. Phospholipase-A2,
group IID (98-fold) and phospholipase-A2, group IIA
(75-fold) have been shown to be up-regulated in human
broncho-epithelial and nasal epithelial cells after treat-
ment with IFNγ [28]. The authors postulated a possible
involvement of both in cytokine-mediated inflammation.
Discussion
The MHC antigens are the main barrier for an acceptance
of the graft by the host organism and antigen presentation
is essential for the activation of T-cells. T-cells are activated
when the TCR recognizes allo-MHC class I molecules in
the case of CD8+ and MHC class II molecules in the case
of CD4+ T-cells [29]. Host T-cells can recognize MHC
antigens by either indirect or direct presentation [30].
During indirect presentation, peptides derived from
donor MHC class I or MHC class II molecules are proc-
essed and presented to CD4+ T-cells by host antigen pre-
senting cells expressing the recipient's MHC class II
molecules. The direct antigen presentation pathway is
unique to transplantation. In this pathway the T-cell
receptors directly recognize an intact MHC molecule
expressed on donor cells. In this context, it is important
that for our studies with acute rejection, nearly all the
genes associated with the antigen processing and presen-
tation pathways were affected (Fig. 3).
Antigen presentation pathway Figure 3
Antigen presentation pathway. Ingenuity Pathways Knowledge Base was used to display pathways containing multiple dif-
ferently expressed genes. Significant up-regulation of genes compared to control was observed in the canonical antigen presen-
tation pathway after allogeneic transplantation. Up-regulated genes are highlighted in red the down-regulated genes are 
highlighted in green. The legend in Fig 3 applies also to Figs. 4-7.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
Page 11 of 16
(page number not for citation purposes)
Our data also indicates that T-cell cytotoxicity is the main
immunological pathway activated in response to acute
rejection in allogeneic transplantation. The cytotoxic mol-
ecules are perforin/granzyme for CD8+ T-cells and the
Fas/Fas-ligand system for CD4+ T-cells [31,32]. In this
context, the absolute changes in expression of genes
involved in antigen processing and presentation by MHC
class I molecules indicates that this part of the antigen
presentation is intensely up-regulated. That is also consist-
ent with the up-regulation of the immunoproteasome and
TAP1/2 transcripts (Fig. 3) likely to be driven by the up-
regulation of interferon γ [33,34], which we have also doc-
umented. IFNγ can also induce the expression of the
chemokines, CXCL9, CXCL10 and CXCL11 [35]. These
data are consistent with other studies showing the
changes in gene expression related to IFNγ or cytotoxic T
lymphocytes in murine transplantation models [12,13].
The induction of tolerance to the graft would be the treat-
ment of choice after transplantation. Increased expression
of protective genes like metallothionein-1 or α2β- crystal-
lin were reported with a mouse cardiac transplant model
[36,37]. In this same context, we observed increased
expression of a number of genes known to have protective
or regulatory properties (Figs. 4, 5, 6, 7) creating a much
more comprehensive list than reported in any previous
studies. Our study also indicates the endogenous activa-
tion of counter regulatory mechanisms within several
pathways that have been linked to acute rejection. For
example, genes with anti- apoptotic functions include B-
cell leukemia/lymphoma 2 related protein A1 (Bfl-1) (Fig.
5) and the Inhibitor of Apoptosis Proteins (IAP) [38,39].
The expression of Heme Oxygenase 1 (HO1; 23-fold) was
induced after allogeneic transplantation. The expression
of HO1 can suppress graft rejection and leads to long term
graft survival in some models [40]. The Cytotoxic T-Lym-
phocyte-Associated protein 4 (CTLA-4) is a negative regu-
lator of T-cells (Fig. 4) [41]. The function of IL10 is to limit
TCR signaling pathway Figure 4
TCR signaling pathway. Ingenuity Pathways Knowledge 
Base was used to display pathways containing multiple differ-
ently expressed genes. Significant up-regulation of genes in 
the canonical TCR signaling pathway was observed after allo-
geneic transplantation. Up-regulated genes are highlighted in 
red the down-regulated genes are highlighted in green.
Apoptosis signaling Figure 5
Apoptosis signaling. In the same way as described in figure 
3 significant regulated genes after allogeneic transplantation 
was observed in the canonical apoptosis signaling Up-regu-
lated genes are highlighted in red the down-regulated genes 
are highlighted in green.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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the action of the immune response. IL10 was initially
characterized as a cytokine produced by Th2-cells, which
inhibited the production of cytokines such as IL2, TNFα
and IFNγ [42]. IL10 also modulates the expression of
chemokines, chemokine receptors and MHC class II mol-
ecules [43]. Thus, the induction of IL10 after allogeneic
transplantation indicates a possible feed back mechanism
of the immune response (Table 1, Fig. 2).
The complement system is part of the innate immune
response. The expression profile we demonstrate in allo-
geneic transplants for a number of complement compo-
nents indicates the activation of the complement cascade
by acute rejection (Fig. 7). Its major function is the elimi-
nation of pathogens and the stimulation of an inflamma-
tory response [44,45]. Local gene expression for
complement components has been shown for C3 and C1
during acute rejection in kidney and heart transplantation
models, respectively [36,46]. One of the novel genes in
our study with the strongest expression after allogeneic
transplantation was the C4b binding protein alpha
(C4bpa; 219 fold up-regulated). C4bpa is a cofactor for
factor 1 in the degradation of C4b in the complement cas-
cade [47]. The degradation of C4b inhibits the formation
of the C4b2a complex, a key step in producing an inflam-
matory response [48].
Interferon signaling Figure 6
Interferon signaling. Significant up-regulation of genes was also observed in the canonical interferon signaling pathway. Up-
regulated genes are highlighted in red.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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Recently regulatory T-cells have been recognized as a
promising tool for the induction of tolerance [49]. In
these studies of our rat renal transplants we also find tran-
scriptional evidence for the presence of regulatory T-cells
within the graft. The function of regulatory T-cells is to
regulate or suppress the activation, regulation and func-
tion of effector T-cells [50]. The development of regula-
tory T-cells appears to be controlled by FoxP3 [18], which
we find is up-regulated after allogeneic transplantation
(Fig. 2). The intragraft expression of FoxP3 has also been
demonstrated in cardiac allograft patients [51]. The pres-
ence of regulatory T-cells within the grafts we studied is
further supported by the concomitant increase in expres-
sion of CD25 [49] and tryptophan hydroxylase [52].
Conclusion
We have used a well-defined rat kidney transplantation
model to demonstrate global changes in gene expression
levels after syngeneic and allogeneic transplantation with
the emphasis on early acute rejection in the allogeneic
transplants. Using DNA microarrays and real time PCR
analysis, we were able to identify major immune effector-
related pathways that are activated after allogeneic trans-
plantation and clearly linked by multiple lines of pub-
lished evidence to acute rejection mechanisms of tissue
injury. That we also found a list of genes that are equally
highly differentially expressed in acute rejection but not
presently linked in the literature represents opportunities
for additional studies and discovery. In parallel, we have
also identified a number of up-regulated genes that are
linked to tissue protective and immune counter-regula-
tion mechanisms. These observations fit with the evolving




Male Lewis-Brown-Norway (LBN) and Lewis (LEW) rats
(250–300 g, Charles River, Sulzfeld, Germany) with free
access to standard rat chow (Ssniff, Soest, Germany) and
tap water were used. Experiments were approved by a gov-
ernmental committee on animal welfare and were per-
formed in accordance with national animal protection
guidelines. Renal transplantation was performed as pub-
lished before [17,53]. For the present study, all recipients
were bilaterally nephrectomized immediately before
transplantation. In brief, the left kidney including ureter,
renal artery, a piece of aorta and renal vein was trans-
planted into the recipient. For the acute rejection-model,
kidneys of LBN-rats (n = 5) were transplanted into LEW-
rats and, for the syngeneic transplantation-model, kidneys
obtained from LBN-rats (n = 5) were transplanted into
LBN-rats. The acute rejection-model leads to marked his-
tological changes typical for acute transplant rejection
Complement cascade Figure 7
Complement cascade. Significant regulated genes after all-
ogeneic transplantation were associated with the canonical 
complement cascade using the Ingenuity Pathways Knowl-
edge Base to visualize genes differently expressed in the 
selected pathway. Up regulated genes are highlighted in red 
the down regulated genes are highlighted in green.BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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[53] For the control group, we used native untreated kid-
neys from LBN-rats (n = 5).
RNA isolation, labeling, hybridization and scanning
On day four after transplantation, the transplanted kid-
neys were removed and total RNA was isolated using RNe-
asy-kit (Qiagen, Hilden, Germany) incubated with 10 U
DNase I (Promega, Heidelberg, Germany) to digest
genomic DNA. RNA quality was measured using the Agi-
lent 2100 BioAnalyzer (Agilent, Palo Alto, CA, USA). Total
RNA was used to prepare biotinylated target RNA. Briefly,
10 μg of total RNA was used to generate first-strand cDNA
by using a T7-linked oligo (dT) primer. After second
strand synthesis, in vitro transcription was performed
with biotinylated UTP and CTP (Enzo Diagnostics, New
York, NY, USA).
Target cDNAs generated from each sample were then
processed as per manufacturer's recommendation using
an Affymetrix GeneChip instrument system. Labeled sam-
ples were hybridized to the Rat Genome 230 2.0 Array.
Arrays were washed and stained with streptavidin-phyco-
erythrin before being scanned on an Affymetrix GeneChip
scanner. Data were analyzed using Affymetrix GCOS array
analysis software. The data discussed in this publication
have been deposited in NCBIs Gene Expression Omnibus
[54] and are accessible through GEO Series accession
number GSE6497.
Statistical analysis
Experiment reports were inspected to assure equal experi-
ment quality. GeneData Refiner (GeneData, Basel, Swit-
zerland) was used to check quality and import
experiments with detection and masking of outliers (the
masked area was 0.026 %, 0.01 % and 0.02 % for the con-
trol, the syngeneic and allogeneic group respectively). The
array defects, assessment using 3'/5' ratios of housekeep-
ing controls, glyseraldehyde-3-phosphate dehydrogenase
(GAPDH) and β-Actin, and condensation of intensities to
signal values using the "Affymetrix Statistical (MAS5)"
method. In GeneData Analyst normalization onto arith-
metic mean 400 was performed. Correlation coefficients
of all pair wise scatter plots were calculated and summa-
rized in a colored matrix. Clustering was done using the
Euclidean distance measure and the complete linkage
method. Correlation coefficients and clustering enable a
visualization and assessment of the experiment structure
based on global expression behavior. Identification of sig-
nificantly different expressed genes between the control,
allogeneic and syngeneic groups were identified using
class comparison with the BRB ArrayTools developed by
Dr. Richard Simon and Amy Peng [55]. The type of uni-
variate test used was a two-sample T-test. Exact multivari-
ate permutations test was computed based on 126
available permutations. Nominal significance level of
each univariate test was set to 0.001. Confidence level of
false discovery rate assessment used was 90 % and the
maximum allowed numbers of false-positive genes were
set to 10.
Functional annotation and pathway analysis
Up- and down-regulated genes in the allogeneic and syn-
geneic groups compared to control group were separately
analyzed to identify enrichment of different functional
pathways and gene ontology (GO) terms [56] using the
Database for Annotation, Visualization, and Integrated
Discovery (DAVID) [22]. The separate analysis of the
down- or up-regulated genes was intended to provide
information on suppressed or induced functions, respec-
tively. The enrichment analysis was performed on the
third GO level, because this gave the best compromise of
specificity and coverage of the gene list. We performed the
analysis with and without setting the filter on the third
GO level. The Rat 230 2.0 gene chip served as the back-
ground list (Fishers exact test with corrected p-value <
0.05, Benjamini & Hochberg [57]). To illustrate the path-
ways with affected genes in the acute rejection group the
data were analyzed through the use of Ingenuity Pathways
Analysis (IPA; Ingenuity® Systems, Redwood City, CA,
USA).
Real time PCR
Expression profiles for selected genes were analyzed by
real time PCR. Total RNA (10 μg) isolated from the same
Table 5: Potential novel transcriptional markers for acute rejection
Fold change Probe set Description Gene symbol
113.071 1378047_at Spi-C transcription factor (Spi-1/PU.1 related) (predicted) Spic_predicted
98.594 1392308_at phospholipase A2, group IID (predicted) Pla2g2d_predicted
94.648 1392496_at Trypsin V-A LOC312273
75.765 1368128_at phospholipase A2, group IIA (platelets, synovial fluid) Pla2g2a
46.437 1369766_at prostaglandin E receptor 2, subtype EP2 Ptger2
39.419 1392171_at chitinase 3-like 1 Chi3l1
30.24 1370869_at branched chain aminotransferase 1, cytosolic Bcat1
26.936 1368413_at amiloride binding protein 1 Abp1BMC Genomics 2008, 9:71 http://www.biomedcentral.com/1471-2164/9/71
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samples was used for cDNA synthesis with the High
Capacity cDNA Reverse Transcription Kit. Real time PCR
was performed using SYBR Green PCR Master Mix or Taq-
Man Universal PCR Master Mix on an ABI PRISM 7700
Sequence Detection System. Specific primer pairs or Taq-
Man Gene expression assays were used. The PCR effi-
ciency of the primers pairs was tested in dilution series
with a cDNA from the allogeneic transplanted group. A
list with the corresponding primer sequences or TaqMan
assay IDs is provided with this manuscript (additional file
3).
All instruments and reagents were purchased by Applied
Biosystems (Darmstadt, Germany). Relative gene expres-
sion values were evaluated with the 2-ΔΔCt method using
GAPDH or 18s-RNA as housekeeping genes [58].
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